AF
TNXP icon

Allworth Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Allworth Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.16K Buy
230
+220
+2,200% +$3.39K ﹤0.01% 4185
2025
Q4 		$157 Buy
+10
New +$184 ﹤0.01% 4732
2025
Q1 		– Hold
0
– -$1 – 4182
2024
Q4 		– Hold
0
– – – 3936
2024
Q3 		– Hold
0
– – – 3744
2024
Q2 		– Hold
0
– – – 3688
2024
Q1 		– Hold
0
– – – 3596
2023
Q1 		– Hold
0
– -$390 – 3291
2022
Q4 		– Hold
0
– – – 2690

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Allworth Financial's TNXP Position: Q1 2026 in Review

Allworth Financial increased its Tonix Pharmaceuticals (TNXP) stake by 2,200% in Q1 2026, buying an estimated $3.39K and bringing the position to 230 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4185.

Allworth Financial first reported a position in TNXP in Q4 2025 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Allworth Financial held 230 shares of Tonix Pharmaceuticals worth $3.16K as of Q1 2026.
  • Allworth Financial bought 220 Tonix Pharmaceuticals shares in Q1 2026, an estimated $3.39K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4185 holding.
  • Allworth Financial first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.